Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foscan-PDT vs Brachytherapy in Recurrent or Persistent Nasopharyngeal Carcinoma
NCT01086488Phase 2Unknown
- Sponsor
- Ministry of Health Malaysia
- Start
- Jan 2009
- Primary completion
- Sep 2011
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of temoporfin in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Ministry of Health Malaysia. Primary endpoint: Complete Tumour Response at 12 months. Status: unknown.
02
Drugs
temoporfin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01086488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086488.